2023 Rosenman ADAPT Finalist, Isaac Health Raises $5.7M

Home » Blog » 2023 Rosenman ADAPT Finalist, Isaac Health Raises $5.7M

2023 ADAPT Finalist, Isaac Health, successfully completed an oversubscribed $5.7 million Seed round to redefine the future of brain healthcare and dementia management. Isaac Health is harnessing advanced technology and predictive machine learning to detect various cognitive and brain health conditions.
From the press release:

NEW YORK–(BUSINESS WIRE)–Isaac Health, a digital health company emerging as a national leader for brain health, announced today the successful completion of its oversubscribed $5.7 million Seed round. The round was led by Meridian Street Capital and B Capital with participation from Primetime Partners, Co-Found Partners, VU Venture Partners, and AirAngels.

“We are thrilled to have secured this significant investment, which reflects the confidence our investors have in the potential for Isaac Health to be the category defining player for brain health,” said Julius Bruch, CEO of Isaac Health. “This funding will enable us to accelerate our mission of providing high-quality patient-centered care for the evaluation and management of dementia and many other brain health conditions.”

Isaac Health partners with health systems and health plans to screen, diagnose, treat, and manage their populations who have brain health conditions, starting with dementia. This strategic funding empowers Isaac Health to further develop and expand its innovative brain health provider platform, driving advancements in the screening, diagnosis, treatment, and management of brain health and dementia. The funding is instrumental in scaling operations and driving strategic partnerships to position Isaac Health as a leader in the rapidly evolving brain health landscape.